Dana Dan Hu-Lowe

Title: Dana Dan Hu-Lowe: Innovator in Monoclonal Antibodies

Introduction

Dana Dan Hu-Lowe is a prominent inventor based in Encinitas, California, known for his significant contributions to the field of biotechnology. He holds a total of six patents, showcasing his innovative approach to developing human monoclonal antibodies.

Latest Patents

Among his latest patents is the invention of human monoclonal antibodies to activin receptor-like kinase-1. This invention relates to antibodies that bind to the extracellular domain of ALK-1 and function to abrogate the ALK-1/TGF-beta-1/Smad1 signaling pathway. The patent also covers methods for making these antibodies, compositions comprising them, and their applications in various therapeutic contexts. Another notable patent involves Alpha5-beta1 antibodies, which are isolated monoclonal antibodies that specifically bind to integrin α5β1 with high affinity. This patent includes nucleic acid molecules encoding the antibodies, expression vectors, and methods for treating various cancers using these antibodies.

Career Highlights

Dana has worked with leading companies in the biotechnology sector, including Pfizer Corporation and Amgen Fremont Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Dana has collaborated with notable professionals in the field, including Michael Aidan North and Xin Jiang. These collaborations have further enhanced his research and development efforts.

Conclusion

Dana Dan Hu-Lowe is a distinguished inventor whose work in monoclonal antibodies has the potential to impact cancer treatment and other therapeutic areas significantly. His innovative spirit and dedication to research continue to drive advancements in biotechnology.